Dr. Anna Lydon is a distinguished oncologist with extensive experience in clinical oncology. Over her career, she has been heavily involved in groundbreaking research and the development of advanced cancer treatments. One of her notable contributions includes the implementation of stereotactic ablative radiotherapy (SABR), which allows for more precise and higher-dose radiotherapy in fewer sessions, significantly benefiting prostate cancer patients. Dr. Lydon is also known for her involvement in various clinical trials aimed at improving treatment outcomes for cancer patients, showcasing her dedication to advancing oncological healthcare through innovative approaches and cutting-edge technology.

• Language: English

• Views592
• Reviews0